Market Research Logo

2015 Global Survey on Liquid Biopsy Adoption Trends

2015 Global Survey on Liquid Biopsy Adoption Trends

The primary goal of this research is to analyze the current and future adoption patterns on the usage of liquid biopsy. Key information the survey seeks to collect include the following:

Current and future use of liquid biopsy by organization type
Timeframe of liquid biopsy adoption amidst future users
Predominantly used cell types—CTCs, ctDNA, cfDNA and EVs—by organization type
Sample inflow to conduct liquid biopsy tests
Preference for sample types: blood, saliva, stool, serum, and so on.
Correlation analysis of sample type and biomarker type
Promising applications for liquid biopsy—current and future
Predominant approaches to liquid biopsy: hotspot panels, single marker tests, and so on
Technologies used to detect ctDNA—current vs. future users
Technologies used to detect CTCs
Vendor popularity for specific biomarkers and reimbursement scenario
Bottleneck to mainstream implementation of liquid biopsy


  • Research Background, Objectives, Methodology, and Respondent Demographics
    • Research Objectives
    • Research Methodology
    • Respondent Demographics
    • Respondent Demographics-Current and Future Users
      • Table Percent of Current and Future Users of Liquid Biopsy, Global, 2015
  • Executive Summary
    • Key Findings
    • Top 7 Brands for Liquid Biopsy
  • Overall Usage of Liquid Biopsy
    • Overall Use of Liquid Biopsy by Organization Type
      • Table Current and Future Users by Organization Type, Global, 2015
    • Timeframe for Future Adoption
      • Table Percent of Future Users by Timeframe, Global, 2015-2017
    • Timeframe for Adoption by Organization Type
      • Table Future User Implementation Plan by Organization Type, Global, 2015
    • Opinion on Use of Liquid Biopsy as an Adjunct to Tissue Biopsy
    • Liquid Biopsy as an Adjunct to Tissue Biopsy
  • Preferred Cell Types and Sample Types for Liquid Biopsy
    • Overall Biomarker Usage
      • Table Work Plan by Cell Type, Global, 2015
    • Overall Biomarker Usage-Hospital Laboratories
      • Table Hospital Laboratories-Work Plan by Cell Type, Global, 2015
    • Overall Biomarker Usage-Pharmaceutical and Diagnostic Companies
      • Table Pharmaceutical and Diagnostic Companies-Work Plan by Cell Type, Global, 2015
    • Overall Biomarker Usage-Reference Laboratories*
      • Table Reference Laboratories-Work Plan by Cell Type, Global, 2015
    • Overall Biomarker Usage-Research Institutes and Universities
      • Table Research Institutes and Universities-Work Plan by Cell Type, Global, 2015
  • Workload Assessment
    • Sample Volume Per Month
      • Table Overall Volume of Sample Per Month, Global, 2015
    • Sample Format-Overall
    • Sample Format-Current Users vs. Future Users
    • Sample Format by Organization Type
  • Predominantly Used Technologies
    • Technologies Used to Detect ctDNA-Overview
      • Table Technologies Used to Detect ctDNA, Global, 2015
    • Technologies Used to Detect ctDNA-Current and Future User Trends
    • Technologies Used to Detect ctDNA by Organization Type
    • Technologies Used to Detect CTC-Overview
      • Table Technologies Used to detect CTCs, Global, 2015
    • Technologies Used to Detect CTC-Current and Future User Trends
    • Technologies Used to Detect CTC by Organization Type
  • Liquid Biopsy-Promising Applications and Bottlenecks
    • Brand Familiarity for Tumor Profiling
    • Promising Applications of Liquid Biopsy (Overall)
    • Promising Applications by Organization Type
    • Promising Applications-Current and Future Users
    • Bottlenecks in Liquid Biopsy
    • Bottlenecks by Biomarker Type
  • Tumor Profiling Approaches, Technologies for Detection
    • Liquid Biopsy Usage to Profile Types
    • Tumor Profiling by Organization Type
    • Liquid Biopsy Approaches-Current vs. Future Users
    • Liquid Biopsy Approach by Organization Type
    • Correlation of Sample Type and Liquid Biopsy Approach
    • CTC-Specific Liquid Biopsy Approaches-Current vs. Future Users
    • ctDNA-Specific Liquid Biopsy Approaches-Current vs. Future Users
    • Germline or cfDNA-Specific Liquid Biopsy Approaches-Current vs. Future Users
    • EVs-Specific Liquid Biopsy Approaches-Current vs. Future Users
  • Brand Perception
    • Overall Brand Perception
    • Brand Perception Organization Type
    • Top 7 Current and Future Brand Perception
    • Brand Preference by Biomarker Type-CTCs
    • Brand Preference by Biomarker Type-CtDNA
    • Brand Preference by Biomarker Type-Germline and cfDNA
    • Brand Preference by Biomarker Type-Evs
  • Reimbursement Scenario
    • Reimbursement Trends (Overall)
    • Reimbursement Trend by Organization Type
    • Reimbursement by Technology-ctDNA
    • Reimbursement by Technology-CTC
  • Mutant Allele Limit (Verbatim Reponses)
    • Mutant Allele Detection Limit-Diagnosis and Monitoring
      • Table Mutant Allele Detection Limit-Diagnosis and Monitoring
  • Reasons for Preferring Blood as a Sample Type (Verbatim Reponses)
    • Reasons for Choosing Blood Over Other Sample Types
  • Appendix
    • Additional Sources of Information

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report